FGFR1/FOXM1 pathway: a key regulator of glioblastoma stem cells radioresistance and a prognosis biomarker

Glioblastoma are known to be aggressive and therapy-resistant tumors, due to the presence of glioblastoma stem cells inside this heterogeneous tumor. We investigate here the involvement of FGFR1 in glioblastoma stem-like cells (GSLC) radioresistance mechanisms. We first demonstrated that the surviva...

Descripción completa

Detalles Bibliográficos
Autores principales: Gouazé-Andersson, Valérie, Ghérardi, Marie-Julie, Lemarié, Anthony, Gilhodes, Julia, Lubrano, Vincent, Arnauduc, Florent, Cohen-Jonathan Moyal, Elizabeth, Toulas, Christine
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2018
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6114977/
https://www.ncbi.nlm.nih.gov/pubmed/30167084
http://dx.doi.org/10.18632/oncotarget.25827

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6114977/
https://www.ncbi.nlm.nih.gov/pubmed/30167084
http://dx.doi.org/10.18632/oncotarget.25827

Ejemplares similares